Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/2007
08/22/2007EP1819823A2 Generation of replication competent viruses for therapeutic use
08/22/2007CN1332712C Oncolytic virus therapy
08/22/2007CN101020053A Prepn process of inactivated rotavirus vaccine
08/21/2007US7259015 Vector system
08/21/2007US7258985 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
08/21/2007US7258865 Immunogens; replication-defective; antibodies; host cells; kits
08/21/2007CA2099069C Recombinant feline herpesvirus vaccine
08/16/2007WO2007091624A1 Novel viral vector
08/16/2007US20070190618 DNA fragments generated from the host cell are enriched by immunoprecipitation; enriched DNA is then hybridized to a microarray comprising sequences complementary to proviral and genomic DNA
08/16/2007US20070190524 Non-M, non-O HIV-1 strains, fragments and uses
08/16/2007US20070190040 Recombinant p53 adenovirus methods and compositions
08/16/2007US20070190033 treatment of a bacterial infection characterized by biofilm formation; for Pseudomonas aeruginosa infections such as those in canine ears
08/16/2007CA2636632A1 Novel viral vector
08/15/2007EP1504088B1 Bacteriophages useful for therapy and prophylaxis of bacterial infections
08/15/2007EP0752888B1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
08/15/2007CN101018860A Flavivirus vaccine
08/15/2007CN101018858A Compositions and methods to prevent AAV vector aggregation
08/15/2007CN101018804A Method of purifying virus envelope
08/15/2007CN101016537A Artificial recombination selection replication type adenovirus and application
08/15/2007CN101015691A Recombinant phages influenza vaccine
08/14/2007US7257365 Using the altered expression patterns of apolipoprotein, haptoglobin, antitrypsin and transthyretin to diagnose virally induced liver inflammation
08/14/2007US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
08/14/2007US7256037 Modified vaccinia Ankara expressing p53 in cancer immunotherapy
08/14/2007US7256036 Blocking receptor binding; gene therapy; gastrin releasing peptide
08/14/2007US7256005 Treating a hepatitis C virus infection with a N-alkylated pyrrolidines, or piperidines, an inhibitor of HCV p7 protein, preventing p7 protein to permeabilize membranes; a kit contains amantadine viricides
08/09/2007WO2007089632A2 Heparin and heparan sulfate binding chimeric vectors
08/09/2007WO2007088882A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell
08/09/2007WO2006130639A3 Novel glutamic acid decarboxylase (gad) chimera and methods of use
08/09/2007US20070186309 Isolated nucleic acid sequence encoding a viral movement protein is used for genetic engineering a plant which is resist to virus, viral disease; transgenic plants, seeds; exogenous gene expression; agriculture crops
08/09/2007US20070185216 Antiviral method
08/09/2007US20070184544 Culturing circular ssDNA viruses for the production of vaccines
08/09/2007US20070184069 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
08/09/2007US20070184025 Chimaeric vector system
08/08/2007EP1815029A2 A novel method for the production and purification of adenoviral vectors
08/08/2007EP1814990A2 Recombinant influenza vectors with tandem transcription units
08/08/2007EP1814982A1 Improved viral purification methods
08/08/2007EP1480671B1 Recombinant rsv virus expression systems and vaccines
08/08/2007EP1122306B1 Novel deoxyribonuclease, gene encoding the same and use thereof
08/08/2007CN1330767C Paramyxorividae virus vector defective in envelope gene
08/08/2007CN101014613A Chimpanzee adenovirus vaccine carriers
08/08/2007CN101012455A Deactivation method of biochemistry substance, preparing method of cardiomyopeptidin and use of cardiomyopeptidin
08/08/2007CN101012454A Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
08/07/2007US7253270 Polynucleotide encoding a mutated HIV gp41 polypeptide
08/07/2007US7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
08/07/2007US7252991 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells
08/07/2007US7252984 La Sota strain of the virus having a mutation in the gene sequences coding for HN and/or F glycoprotein(s): genetic engineering; also administrable post-hatch; birds; poultry; veterinary medicine; infectious bronchitis and bursal disease; adenovirus, reovirus, pox diseases; laryngotracheitis; influenza
08/07/2007US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells
08/07/2007CA2252374C A process for viral inactivation of lyophilized blood proteins
08/07/2007CA2183079C Method for preparing a multicombinatorial library of antibody gene expression vectors
08/07/2007CA2182888C Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor
08/02/2007WO2007067386A3 An hiv-1 latency model for high throughput screening
08/02/2007WO2007047728A3 Compositions and methods for the treatment of canine influenza virus disease
08/02/2007WO2007044024A3 Recombinant influenza vectors with tandem transcription units
08/02/2007WO2006078766A3 Methods and compositions for metastatic tumor screening
08/02/2007WO2005012545A3 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors
08/02/2007US20070178592 Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same
08/02/2007US20070178576 Purification of high-molecular compounds by means of affinity membrane chromatography
08/02/2007US20070178563 Mosaic infectious bursal disease virus vaccines
08/02/2007US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
08/02/2007US20070178448 Selective posttranslational modification of phage-displayed polypeptides
08/02/2007US20070178120 Virus-like particles as vaccines for paramyxovirus
08/02/2007US20070178119 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier
08/02/2007US20070178069 Herpes simplex virus vector
08/02/2007CA2535127A1 H3 equine influenza a virus
08/01/2007EP1813676A2 Retroviral vectors pseudotyped with influenza virus hemagglutin for gene delivery
08/01/2007EP1812573A1 Mutant porcine reproductive and respiratory syndrome virus
08/01/2007EP1812564A2 Defective influenza virus particles
08/01/2007EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy
07/2007
07/31/2007US7250299 Lentiviral packaging system and transfer vector; a heterologous gene operably linked to a regulatory element, vector that encodes a gag gene or a pol gene; and a regulatory lentiviral vector of a rev gene,
07/31/2007US7250293 Complementing cell lines
07/31/2007US7250251 For detection of infection of a target cell by an enveloped retroviral virion human immunodeficiency virus (HIV); chimeras; kits
07/31/2007US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides
07/26/2007WO2007083644A1 Novel protein expression system
07/26/2007WO2007047578A3 Cell display of antibody libraries
07/26/2007WO2004098530A3 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
07/26/2007US20070172949 For use in systems for delivering and expressing desired genes and gene sequences; genetic engineering; gene therapy
07/26/2007US20070172936 Purified active HCV NS2/3 protease
07/26/2007US20070172930 process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof
07/26/2007US20070172494 Cold-adapted equine influenza viruses
07/26/2007CA2638904A1 Methods for profiling transcriptosomes
07/26/2007CA2636600A1 Novel protein expression system
07/25/2007EP1171624B1 Method and means for producing high titer, safe, recombinant lentivirus vectors
07/25/2007EP0840624B1 Apparatus for inactivating viral contaminants in blood products
07/25/2007CN1328373C Porcine circus-virus 2 type recombinant adenovirus and vaccine
07/25/2007CN1328372C Tumor target gene-virus ZD55-IL-24, construction method and application thereof
07/25/2007CN101006180A Virus particle containing a vector derived from alpha virus and its preparation method
07/25/2007CN101003794A Method for constructing recombined adenovirus in PEX outer secretion type of human and application
07/25/2007CN101003793A Technique for cleaning pathogenesis bacteria in environment by phages
07/24/2007US7247716 Recombinant sequence, its preparation and use
07/24/2007US7247703 Anticancer agents; protein complex
07/24/2007US7247472 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
07/24/2007CA2097185C Viral recombinant vectors for expression in muscle cells
07/24/2007CA2097019C Process for attenuated varicella zoster virus vaccine production
07/19/2007WO2007080123A1 Method for determining the concentration of virus particles/virus antigens
07/19/2007WO2007048086A9 Canine influenza virus and related compositions and methods of use
07/19/2007WO2007046839A3 New live virus vaccines
07/19/2007WO2006136448A3 Attenuated sars and use as a vaccine
07/19/2007US20070167610 Recombinant soluble adenovirus receptor
07/19/2007US20070166820 Alphavirus replicons and helper constructs
07/19/2007US20070166802 West nile vaccine